PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
PT Kalbe Farma Gross Profit Margin (Quarterly) : 35.90% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.90% |
| March 31, 2026 | 37.24% |
| December 31, 2025 | 36.36% |
| September 30, 2025 | 38.10% |
| June 30, 2025 | 39.13% |
| March 31, 2025 | 40.08% |
| December 31, 2024 | 39.76% |
| September 30, 2024 | 37.22% |
| June 30, 2024 | 38.05% |
| March 31, 2024 | 38.49% |
| December 31, 2023 | 35.75% |
| September 30, 2023 | 35.80% |
| June 30, 2023 | 39.06% |
| March 31, 2023 | 39.71% |
| December 31, 2022 | 37.10% |
| September 30, 2022 | 38.82% |
| June 30, 2022 | 40.38% |
| March 31, 2022 | 40.41% |
| December 31, 2021 | 40.56% |
| September 30, 2021 | 41.42% |
| June 30, 2021 | 41.85% |
| March 31, 2021 | 42.32% |
| December 31, 2020 | 39.02% |
| September 30, 2020 | 44.78% |
| June 30, 2020 | 43.82% |
| Date | Value |
|---|---|
| March 31, 2020 | 43.61% |
| December 31, 2019 | 41.41% |
| September 30, 2019 | 44.47% |
| June 30, 2019 | 44.80% |
| March 31, 2019 | 45.18% |
| December 31, 2018 | 42.57% |
| September 30, 2018 | 45.62% |
| June 30, 2018 | 46.64% |
| March 31, 2018 | 47.19% |
| December 31, 2017 | 46.65% |
| September 30, 2017 | 47.17% |
| June 30, 2017 | 47.31% |
| March 31, 2017 | 47.79% |
| December 31, 2016 | 47.93% |
| September 30, 2016 | 47.79% |
| June 30, 2016 | 48.00% |
| March 31, 2016 | 46.78% |
| December 31, 2015 | 45.08% |
| September 30, 2015 | 46.51% |
| June 30, 2015 | 47.89% |
| March 31, 2015 | 48.27% |
| December 31, 2014 | 49.76% |
| September 30, 2014 | 47.12% |
| June 30, 2014 | 46.85% |
| March 31, 2014 | 46.70% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Avadel Pharmaceuticals Plc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.75% |
| Return on Assets | 11.89% |
| Return on Invested Capital | 14.43% |
| Profit Margin (Quarterly) | 9.39% |
| Operating Margin (Quarterly) | 11.80% |
| Return on Net Operating Assets | 14.75% |